Stocks福泰制药VRTX

VRTX

福泰制药

273.51 -6.90 (-2.46%)
延遲價格來源為納斯達克, 美元 市場休市
交易
273.51
274.17
已置頂的帖子
Genome Engineering
Vertex, Verve team up to develop a gene editing drug for liver disease 🔹 $VRTX (Vertex Pharmaceuticals Incorporated) is broadening its reach in gene editing, announcing Wednesday a deal with $VERV (Verve Therapeutics Inc) to develop a one-time treatment for an undisclosed liver disease. Vertex will... 顯示更多 翻譯